Baker McKenzie advised Numab Therapeutics on the deal. Numab Therapeutics closed a CHF 100 million (approximately USD 110 million) Series C financing. Numab Therapeutics is a clinical...
Numab Therapeutics’ CHF100 Million Series C Financing
Deutsche Börse’s Acquisition of Minority Stake in Clearstream Fund Centre
Baker McKenzie has acted as legal adviser to UBS Group and UBS AG. Bär & Karrer acts as legal advisor to Deutsche Börse Group on this...